Cigna CO-50 Medical Necessity Denials in Dermatology
Non-covered services; not deemed medically necessary. Real-world appeal strategy, filing deadlines, and copy-paste letter template for Cigna dermatology claims.
Verify before filing
Filing deadlines, appeal addresses, and policy criteria described here reflect typical payer behavior at publication. Cigna updates policies frequently and plan-level rules vary by employer group, state, and line of business. Always cross-check the specific deadline and filing address on your EOB, and confirm current Cigna medical-policy language through the provider portal before submitting an appeal.
Why Cigna throws CO-50 for dermatology
Understanding the specific combination of payer policy, specialty workflow, and CARC mechanics is what separates an easy fix from an endless appeal loop.
Cigna's CO-50 denials in dermatology concentrate on the cosmetic-medical boundary. Procedures that can be either cosmetic or medically necessary. Destruction of benign lesions (17110, 17111), laser treatments, and certain excisions. Frequently trigger CO-50 when Cigna's UM team determines the indication was cosmetic.
Also heavily denied: Botox for medical indications (hyperhidrosis G90.9, chronic migraine G43.709). Cigna covers Botox for these indications but requires very specific documentation. Failed prior treatments (topical antiperspirants, oral anticholinergics for hyperhidrosis; standard migraine prophylaxis for chronic migraine), symptom frequency meeting threshold (migraines over 15 days per month for chronic migraine), and exact dosing per FDA-approved protocol.
Mohs surgery on the trunk/extremities (not head/neck/hands/feet/genitalia) triggers CO-50 when the high-risk feature documentation is insufficient. Cigna requires specific findings: positive margins on prior excision, aggressive histologic subtype, size over 2cm, recurrent lesion, immunosuppressed patient, or location with high recurrence risk.
Dermatology CO-50 appeals win when the documentation explicitly addresses Cigna's Medical Coverage Policy criteria point-by-point. Generic clinical narratives lose; structured criteria-matched notes win.
Cigna's denial profile is dominated by Evicore-vendored prior-auth gates for high-dollar diagnostic imaging, musculoskeletal procedures, and behavioral health. Medical-necessity denials reference Cigna Medical Coverage Policies (MCPs).
Cigna for Providers (cignaforhcp.cigna.com) handles claim status, corrected claims, and appeals. Evicore manages radiology, cardiology, musculoskeletal, and oncology prior-auth for Cigna commercial plans.
- Reconsideration via Cigna for Providers portal
- Formal written appeal to Cigna Provider Appeals
- Peer-to-peer through Evicore (for Evicore-denied services) or Cigna UM
- External review via the plan or state DOI
Dermatology coverage-policy gotchas
Dermatology denials cluster around cosmetic vs medical boundary questions, biologic-drug prior-auth, and Mohs surgery coverage criteria.
Biologics (Dupixent, Cosentyx, Skyrizi) require prior-auth with failed conventional therapy documentation at every commercial payer. Mohs surgery outside head/neck/hands/feet triggers medical-necessity review. Cosmetic-adjacent procedures (like Botox for hyperhidrosis) need precise ICD-10 and documentation to survive CO-204 denials.
Exact fix: step by step
Specific, actionable workflow. Not theory. What to pull, what to attach, where to file.
Pull the Cigna Medical Coverage Policy cited on the EOB. For benign lesion destruction: attach photos, size measurements, symptom documentation (irritation, bleeding, pain, rapid growth), and any documentation of prior malignant history or family history supporting concern.
For Botox for medical indications: attach failed-treatment documentation (at least 2 prior therapies tried, dose, duration, reason for failure), a symptom log showing frequency/severity meeting coverage threshold, and dosing within FDA-approved protocol.
For Mohs on trunk/extremities: attach biopsy pathology, a diagram of the lesion with measurements, and specific documentation of the high-risk feature (size, recurrence, aggressive subtype, immunosuppression, cosmetically sensitive site rationale).
For evicore-vendored prior-auth denials that became CO-50 post-claim: the retro-auth pathway through Evicore is often better than the appeal pathway through Cigna directly.
Cigna filing deadline
- Formal appeal180 days
- Corrected claim90 days
- Peer-to-peerWithin 14 days
Cigna 180-day appeal window. Evicore retro-auth requests are usually decided within 5 business days. Peer-to-peer with the vendor or with Cigna UM is available for denied retro-auths.
Copy-paste appeal letter
Specialty-tuned template with placeholder fields. Swap in your patient details, dates, and clinical specifics. Attach the documentation listed at the bottom of the letter.
[Practice Letterhead] [Date] Cigna Provider Appeals [Address from EOB] Re: Appeal of CO-50 Medical Necessity Denial Member: [Patient Name] Member ID: [Member ID] Date of Service: [DOS] Claim Number: [Claim #] CPT: [e.g., 17110 - Destruction of benign lesion; or 96372/J0585 - Botox injection] Cigna Medical Coverage Policy: [MCP number] To Whom It May Concern: We appeal the CO-50 denial. The documentation meets Cigna MCP [number] criteria for medical-necessity coverage. Clinical Indication: [Patient] with [diagnosis, ICD-10] has [specific findings]. The service was medically necessary due to: [For benign lesion destruction] - Size: [X mm/cm documented] - Symptoms: [irritation, bleeding, pain, rapid growth with dates] - Location: [anatomic impact on function/clothing contact] - Pathology: [if biopsied, result] [For Botox medical indication] - Prior failed treatments: [Treatment 1 name/dose/duration/response; Treatment 2 same] - Symptom frequency: [X days per month meeting MCP threshold] - Dosing: [within FDA protocol for indication] [For Mohs trunk/extremity] - Biopsy: [pathology, subtype, margin status] - High-risk feature: [size >2cm / recurrent / aggressive subtype / immunosuppressed / location] - Size: [X cm measured] Documentation attached: 1. Clinical H&P with documented medical indication 2. Photographs with measurements (where applicable) 3. Prior treatment documentation (for Botox) 4. Biopsy pathology (for Mohs) 5. Cigna MCP [number] criteria worksheet [Dr. Name] is available for peer-to-peer. Sincerely, [Name]
Every bracketed field in the template is a data point or document you must provide. Missing any of these is the single largest cause of appeal denials. Build a pre-filing checklist from the “Documentation attached” section of the letter above.
High-risk CPTs for this combo
These CPT codes trigger CO-50 denials at Cigna most frequently in dermatology claims. Watch them in your denial dashboard.
Get a free AR denial audit of your dermatology claims.
Upload your denial export. Our AI classifies every CO-50, CO-50, CO-97, CO-16, and CO-204 line by root cause, then surfaces which ones are actually recoverable. AAPC-certified review. Written report in your inbox. Usually inside an hour.
Common questions on this scenario
What does CO-50 mean when Cigna denies a dermatology claim?
CO-50 is a CARC denial for non-covered services; not deemed medically necessary. In Dermatology practice with Cigna, this typically fires on 17110, 17111, 17311 and similar high-risk CPTs.
What is Cigna's filing deadline for CO-50 appeals?
Cigna 180-day appeal window. Evicore retro-auth requests are usually decided within 5 business days. Peer-to-peer with the vendor or with Cigna UM is available for denied retro-auths.
What is the typical overturn rate for CO-50 appeals in dermatology?
55-70 percent with criteria-matched documentation. Success depends heavily on documentation quality and whether clinical criteria in Cigna's medical policy are matched point-by-point.
Can I file a corrected claim or must I file a formal appeal?
Start with corrected claim if the fix is administrative (wrong modifier, auth number mismatch). File formal appeal when clinical medical necessity is the dispute.
Sources and review
What this guide is based on
- Cigna public provider manual and medical-policy library
- X12 CARC / RARC code set (maintained by the ASC X12 committee)
- CMS Local Coverage Determinations and National Coverage Determinations database
- MGMA, HFMA, and Change Healthcare denial-rate benchmarks for industry context
- AAPC-credentialed coder review of appeal-strategy guidance
What you should verify yourself
Overturn-rate ranges reflect typical patterns and AAPC reviewer consensus, not payer-published statistics. Filing deadlines and appeal addresses vary by plan, state, and employer group. Always confirm on the EOB for the specific claim and on the payer’s current provider portal before filing.
This content is provided for educational and informational purposes only. It is not legal, clinical, or coding advice. Go Medical Billing LLC makes no guarantee of appeal outcomes; overturn rates depend on the specific claim, documentation, and payer-plan combination.
Stop losing revenue to CO-50 denials
We audit dermatology practices' Cigna denials and recover what your team is writing off. Free audit. AAPC-certified coders. 2.49 percent of collections.